NASDAQ:CYCCP

Cyclacel Pharmaceuticals Earning Date

USA |NASDAQ |USD

CYCCP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Sep 30, 2021 (est) Jun 30, 2021 - $-0.56 $-0.47
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Sep 30, 2021 (est) Jun 30, 2021 - $0.00 $0.00

Cyclacel Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.

CYCCP Earnings Date & History Chart

CYCCP Earnings Date & Revenue History

CYCCP Earnings History

|
Show More
Show More

CYCCP Revenue History

|
Show More
Show More

Cyclacel Pharmaceuticals Next Earnings Date & Report

CYCCP Jun 2021 (FQ) Earnings Date & Report Preview

CYCCP's next estimated earnings date (based on same quarter last year's report date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.

Cyclacel Pharmaceuticals Previous Earnings Dates & Reports

CYCCP Previous Earnings Date & Report Recap: Mar 2021 (FQ)

Cyclacel Pharmaceuticals's previous earnings date was Jun 30, 2021 for its fiscal quarter ended Mar 31, 2021.

CYCCP's earnings per share (EPS) was $-0.56.

The EPS was lower than the previous fiscal quarter (Dec 2020) by 12.80%, and higher than the same period a year before (Mar 2020) by -2.61%.

Revenues were $0.00.

The company reported a net income of $-3.48M.

Free cash flow for the quarter was $-3.64M , compared to $-1.19M last quarter and $-2.81M a year before.

CYCCP ended the quarter with $996.00K in total debt, a decrease of -5.77% compared to the previous quarter, and a decrease of -7.18% compared to the same quarter a year before.

CYCCP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cyclacel Pharmaceuticals's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

CYCCP's earnings per share (EPS) was $-2.89.

Revenues were $5.88K.

The company reported a net income of $-8.45M.

Cyclacel Pharmaceuticals reported a free cash flow of $-8.03M for its fiscal year, compared to $-9.46M a year ago.

The company ended the fiscal year with $1.06M in total debt, a decrease of -11.25% compared to the previous year.